Related Experiment Video
Updated: Aug 12, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Regulation of arachidonic acid mobilization in lipopolysaccharide-activated P388D(1) macrophages by adenosine
M A Balboa1, J Balsinde, C A Johnson
1Department of Chemistry and Biochemistry, University of California at San Diego, La Jolla, California 92093-0601, USA.
Abstract:
Murine P388D(1) macrophages exhibit a delayed prostaglandin biosynthetic response when exposed to bacterial lipopolysaccharide (LPS) for prolonged periods of time that is dependent on induction of the genes coding for Group V secretory phospholipase A(2) and cyclooxygenase-2. We herein report that LPS-induced arachidonic acid (AA) metabolite release in P388D(1) macrophages is strongly attenuated by the P2X(7) purinergic receptor antagonists periodate-oxidized ATP and pyridoxal-phosphate-6-azophenyl-2', 4'-disulfonic acid, and this is accompanied by suppression of the expression of both Group V secretory phospholipase A(2) and cyclooxygenase-2. The effect appears to be specific for LPS, because the P2 purinergic receptor antagonists do not affect P388D(1) cell stimulation by other stimuli such as platelet-activating factor or the Ca(2+) ionophore A23187. Moreover, extracellular nucleotides are found to stimulate macrophage AA mobilization with a pharmacological profile that implicates the participation of the P2X(7) receptor and that is inhibited by periodate-oxidized ATP. Collectively these results demonstrate coupling of the P2X(7) receptor to the AA cascade in P388D(1) macrophages and implicate the participation of this type of receptor in LPS-induced AA mobilization.
Insights
Bacterial lipopolysaccharide (LPS) triggers delayed prostaglandin synthesis in macrophages via P2X7 receptors. Blocking these receptors with antagonists suppresses arachidonic acid release and key enzyme expression, revealing a novel signaling pathway.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Macrophages play a crucial role in inflammatory responses.
- Lipopolysaccharide (LPS) from bacteria is a potent immune activator.
- Prostaglandin synthesis is a key component of the inflammatory cascade.
Purpose of the Study:
- To investigate the role of P2X7 purinergic receptors in LPS-induced prostaglandin biosynthesis in P388D(1) macrophages.
- To elucidate the signaling pathways involved in LPS-mediated arachidonic acid mobilization.
Main Methods:
- Treatment of P388D(1) macrophages with LPS.
- Application of P2X7 receptor antagonists (periodate-oxidized ATP and pyridoxal-phosphate-6-azophenyl-2', 4'-disulfonic acid).
- Measurement of arachidonic acid metabolite release and expression of Group V secretory phospholipase A(2) and cyclooxygenase-2.
Main Results:
- P2X7 receptor antagonists significantly attenuated LPS-induced arachidonic acid metabolite release.
- Antagonist treatment suppressed the expression of Group V secretory phospholipase A(2) and cyclooxygenase-2.
- The observed effects were specific to LPS stimulation, not affecting responses to platelet-activating factor or Ca(2+) ionophore.
Conclusions:
- The P2X7 purinergic receptor is coupled to the arachidonic acid cascade in P388D(1) macrophages.
- P2X7 receptor activation is implicated in LPS-induced arachidonic acid mobilization and subsequent prostaglandin synthesis.
More Related Videos
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
IP3/DAG Signaling Pathway